-
3 Branded Generics, Fermentation-Based Ingredients and Latin America Generics Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories
- October 22, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
No Comments
Branded Generic and Ingredient Stocks with a strong future roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Latin America Generics, Custom Synthesis Ingredients and Finished Dosages Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India
- October 22, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Emerging Market and API Pharma Stocks with a strong future roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Domestic Brand Leader, Latin America Generics and Process Chemistry Stocks With a Strong Future Roadmap: Mankind Pharma, Caplin Point Laboratories and Neuland Laboratories
- October 21, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Domestic and Export Pharma Stocks with a strong future roadmap: Mankind Pharma, Caplin Point Laboratories and Neuland Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Injectable and Contract Formulation Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Venus Remedies and Syncom Formulations (India)
- October 7, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Caplin Point Laboratories, Venus Remedies and Syncom Formulations (India) compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
- 1
- 2